天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Home Cart 0 Sign in  

[ CAS No. 112811-72-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 112811-72-0
Chemical Structure| 112811-72-0
Structure of 112811-72-0 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 112811-72-0 ]

Related Doc. of [ 112811-72-0 ]

Alternatived Products of [ 112811-72-0 ]
Product Citations

Product Details of [ 112811-72-0 ]

CAS No. :112811-72-0 MDL No. :MFCD05864420
Formula : C14H11F2NO4 Boiling Point : -
Linear Structure Formula :- InChI Key :WQJZXSSAMGZVTM-UHFFFAOYSA-N
M.W : 295.24 Pubchem ID :7019465
Synonyms :
Chemical Name :1-Cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

Calculated chemistry of [ 112811-72-0 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 21
Num. arom. heavy atoms : 10
Fraction Csp3 : 0.29
Num. rotatable bonds : 3
Num. H-bond acceptors : 6.0
Num. H-bond donors : 1.0
Molar Refractivity : 70.34
TPSA : 68.53 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.18 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.81
Log Po/w (XLOGP3) : 2.71
Log Po/w (WLOGP) : 3.1
Log Po/w (MLOGP) : 1.48
Log Po/w (SILICOS-IT) : 2.73
Consensus Log Po/w : 2.37

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -3.53
Solubility : 0.0867 mg/ml ; 0.000294 mol/l
Class : Soluble
Log S (Ali) : -3.8
Solubility : 0.0465 mg/ml ; 0.000158 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.43
Solubility : 0.109 mg/ml ; 0.000368 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 2.36

Safety of [ 112811-72-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 112811-72-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 112811-72-0 ]
  • Downstream synthetic route of [ 112811-72-0 ]

[ 112811-72-0 ] Synthesis Path-Upstream   1~2

  • 1
  • [ 112811-72-0 ]
  • [ 151213-40-0 ]
  • [ 186826-86-8 ]
YieldReaction ConditionsOperation in experiment
3.3 g
Stage #1: With 1,8-diazabicyclo[5.4.0]undec-7-ene In acetonitrile at 20 - 85℃; for 36 h; Inert atmosphere
Stage #2: With hydrogenchloride In water at 15℃; for 1 h; Inert atmosphere
Under nitrogen protection, 1-cyclopropyl-6, 7-difluoro-1, 4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid 10.0 g (0·0339 mοl) and (S,S) -2,8-diazabicyclo[4,3,0] nonane 5 .13g(0.0406mol)were added to 70 mL acetonitrile, it was stirred at 20 ° C~30 ° C and 1,8-diazabicyclo[5·4·0]undec-7-ene 7.74 g (0.0508 mol) was added, it was stirred at 75 ° C~85 ° C for 36 h. Concentrated in vacuo (temperature 45 ° C ~ 65 ° C, pressure -0 · 08MPa ~ -0.1MPa) to remove most of the solvent, it was then dissolved in chloroform, the mass concentration is 2percent aqueous acetic acid solution (the mass concentration refers to the mass of acetic acid as a percentage of the total mass of the aqueous acetic acid solution), the mass concentration was 10percent saline (the mass concentration refers to the mass of sodium chloride as a percentage of the total mass of brine were sequentially added, respectively, then the mixture was stirred, allowed to stand, and the aqueous layer was separated. The organic layer was concentrated in vacuo (temperature 35 ° C ~ 55 ° C, pressure -0.08MPa ~ -0.1MPa) to remove most of the solvent, ethyl acetate was added, and the mixture was cooled to 10 ° C to 20 ° C and stirred for 2 hours to 3 hours. Centrifugation, rinsed three times with ethyl acetate, dried in vacuo (vacuum degree -0.01MPa~-0.1MPa, temperature 45~55°C) dried for 14 to 18 hours, to obtain 4.01g of moxifloxacin , yield 29.5percent.HPLC purity 93.54percent. Under nitrogen protection, add 4.0 g of moxifloxacin to 2.5 mL of water and 10 mL of methanol.Stir at 170 ° C for 1 hour, filter, and cool to 35 ° C.The pH was adjusted to 1.4 to 1.8 by the addition of 6N hydrochloric acid. Cool to 15 ° C and stir for 1 hour.It was filtered, washed with water, and stirred at 15 ° C for 1 hour in a solution of water 5 mL and concentrated hydrochloric acid.Filtered, washed with water, vacuum dried (vacuum degree - 0.01 MPa ~ -0.1 MPa, temperature 45 ~ 55 ° C) for 16 hours, to obtain 3.3 g of moxifloxacin hydrochloride,Yield 75.6percent (total yield 22.3percent, based on 1-cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid ). The HPLC purity was 99.23percent, and the maximum single impurity was 0.47percent.
Reference: [1] Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2014, vol. 121, p. 254 - 258
[2] Patent: CN109096276, 2018, A, . Location in patent: Paragraph 0090-0093
  • 2
  • [ 112811-72-0 ]
  • [ 186826-86-8 ]
Reference: [1] Patent: EP2551268, 2013, A1,
[2] Patent: US2013/59880, 2013, A1,
[3] Patent: WO2014/87292, 2014, A1,
[4] Patent: CN109096276, 2018, A,
[5] Patent: CN109096276, 2018, A,
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 112811-72-0 ]

Fluorinated Building Blocks

Chemical Structure| 177325-13-2

[ 177325-13-2 ]

(S)-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid hydrochloride

Similarity: 0.83

Chemical Structure| 226578-51-4

[ 226578-51-4 ]

(S)-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid methanesulfonic acid salt

Similarity: 0.78

Chemical Structure| 182868-72-0

[ 182868-72-0 ]

1-Cyclopropyl-8-ethoxy-6-fluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

Similarity: 0.76

Chemical Structure| 97867-33-9

[ 97867-33-9 ]

1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid 2-hydroxypropanoic acid salt

Similarity: 0.74

Chemical Structure| 154093-72-8

[ 154093-72-8 ]

1-Cyclopropyl-6,7-difluoro-8-hydroxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

Similarity: 0.73

Ethers

Chemical Structure| 182868-72-0

[ 182868-72-0 ]

1-Cyclopropyl-8-ethoxy-6-fluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

Similarity: 0.76

Chemical Structure| 88377-31-5

[ 88377-31-5 ]

5-Methoxy-9-oxo-9,10-dihydroacridine-4-carboxylic acid

Similarity: 0.74

Chemical Structure| 338747-41-4

[ 338747-41-4 ]

1-(4-Methoxybenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

Similarity: 0.72

Chemical Structure| 126480-32-8

[ 126480-32-8 ]

2-Amino-3-methoxy-4-fluorobenzoic acid

Similarity: 0.72

Chemical Structure| 112811-71-9

[ 112811-71-9 ]

Ethyl 1-cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylate

Similarity: 0.71

Ketones

Chemical Structure| 177325-13-2

[ 177325-13-2 ]

(S)-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid hydrochloride

Similarity: 0.83

Chemical Structure| 226578-51-4

[ 226578-51-4 ]

(S)-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid methanesulfonic acid salt

Similarity: 0.78

Chemical Structure| 182868-72-0

[ 182868-72-0 ]

1-Cyclopropyl-8-ethoxy-6-fluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

Similarity: 0.76

Chemical Structure| 97867-33-9

[ 97867-33-9 ]

1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid 2-hydroxypropanoic acid salt

Similarity: 0.74

Chemical Structure| 88377-31-5

[ 88377-31-5 ]

5-Methoxy-9-oxo-9,10-dihydroacridine-4-carboxylic acid

Similarity: 0.74

Carboxylic Acids

Chemical Structure| 177325-13-2

[ 177325-13-2 ]

(S)-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid hydrochloride

Similarity: 0.83

Chemical Structure| 226578-51-4

[ 226578-51-4 ]

(S)-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid methanesulfonic acid salt

Similarity: 0.78

Chemical Structure| 182868-72-0

[ 182868-72-0 ]

1-Cyclopropyl-8-ethoxy-6-fluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

Similarity: 0.76

Chemical Structure| 97867-33-9

[ 97867-33-9 ]

1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid 2-hydroxypropanoic acid salt

Similarity: 0.74

Chemical Structure| 88377-31-5

[ 88377-31-5 ]

5-Methoxy-9-oxo-9,10-dihydroacridine-4-carboxylic acid

Similarity: 0.74

Related Parent Nucleus of
[ 112811-72-0 ]

Quinolines

Chemical Structure| 182868-72-0

[ 182868-72-0 ]

1-Cyclopropyl-8-ethoxy-6-fluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

Similarity: 0.76

Chemical Structure| 97867-33-9

[ 97867-33-9 ]

1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid 2-hydroxypropanoic acid salt

Similarity: 0.74

Chemical Structure| 154093-72-8

[ 154093-72-8 ]

1-Cyclopropyl-6,7-difluoro-8-hydroxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

Similarity: 0.73

Chemical Structure| 93107-30-3

[ 93107-30-3 ]

1-Cyclopropyl-6,7-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

Similarity: 0.73

Chemical Structure| 94695-52-0

[ 94695-52-0 ]

1-Cyclopropyl-6,7,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

Similarity: 0.73

; ;